Skip to content

Specialized Cohort Study on Integrated Traditional Chinese and Western Medicine Treatment for Heart Failure

Specialized Cohort Study on Integrated Traditional Chinese and Western Medicine Treatment for Heart Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120416
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Sponsors

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for heart failure (refer to the National Heart Failure Guidelines 2023); 2. For the retrospective cohort study, the completeness of case data should be >=70%; 3. For the prospective cohort study, informed consent must be signed.

Exclusion criteria

Exclusion criteria: 1. Severe lack of case data (e.g., no clear diagnostic basis, key diagnostic and treatment information not recorded); 2. Prospective cases refuse to cooperate with follow-up or are unable to provide valid contact information.

Design outcomes

Primary

MeasureTime frame
Cardiovascular death;Readmission due to worsening heart failure;Adverse cardiovascular events;N-terminal pro-B-type natriuretic peptide,NT-proBNP;Brain Natriuretic Peptide,BNP;New York Heart Association (NYHA) Functional Classification;Kansas City Cardiomyopathy Questionnaire (KCCQ);TCM syndrome score;Laboratory examination;Imaging examinations;

Countries

China

Contacts

Public ContactWang Xianliang

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

xlwang1981@126.com+86 139 2000 7825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026